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The relationship between insurance and
health outcomes of diabetes mellitus
patients in Maryland: a retrospective
archival record study
Soo-Hoon Lee, Samuel L. Brown* and Andrew A. Bennett
Abstract
Background: Past studies examining the health outcomes of diabetes mellitus (DM) patients found that social
determinants of health disparities were associated with variabilities in health outcomes. However, improving access
to healthcare, such as health insurance, should mitigate negative health outcomes. The aim of the study was to
explore the association between four types of health insurance, namely, Medicare Fee-For-Service (FFS), Medicare
Managed Care (MC), Private FFS, and Private MC plans, and the health outcomes of DM patients, controlling for
patients’ social determinants of health.
Methods: This is a retrospective cross-sectional archival record study to explore the relationships between types of
health insurance and health outcomes of DM patients who were at least 65 years old, or the elderly. Data was
drawn from the 2012 Maryland Clinical Public Use Data and received an exempt status from our Institutional
Review Board. Elderly Maryland residents with chronic DM were included in the study, resulting in a sample size of
43,519 individuals. Predictor variables were four types of insurance and health outcome variables were length of
hospital stay (LOS), 30-day readmission, and end-stage renal disease (ESRD). Control variables included hospital
characteristics, patient characteristics, and social determinants of health. Student’s t-tests determined the statistical
differences for the control variables between the types of insurance. Multiple hierarchical regression analysis was
applied to test the association between insurance plans and LOS, while logistic regression analyses were applied to
test the association between insurance plans with 30-day readmission and ESRD. Statistical significance was set at
p < 0.05.
Results: t-test results indicated minimal statistical differences between the health statuses of patients enrolled in
different insurance plans. After factoring out the control variables, regression analyses indicated that Medicare FFS
patients had the worst outcome for LOS, 30-day readmission, and ESRD rates. Although patients on Medicare MC
plans had lower LOS, 30-day readmission, and ESRD rates compared to those on Medicare FFS, patients enrolled in
Private MC plans had the lowest odds of a 30-day readmission and patients enrolled in Private FFS had the lowest
odds of an ESRD.
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Conclusions: The data suggests that insurance plans were related to the health outcomes of elderly DM patients
after considering their social determinants of health. Specifically, DM patients enrolled in managed care and private
insurance plans had better health outcomes compared to those on Medicare FFS plans.
Keywords: Medicare fee-for-service, Medicare managed care, Private insurance, Diabetes mellitus, Length of stay,
30-day readmission, End-stage-renal-disease
Introduction
Diabetes mellitus (DM) is a chronic illness in which
there is no cure and patients require constant access to
healthcare. Worldwide, the number of people with DM
increased from 108 million in 1980 to 422 million in
2014 [1]. This number is projected to increase to 552
million by 2030 due to population growth, aging,
urbanization, and the increased prevalence of obesity
and physical inactivity [2].
Although DM patients represented 9.4% of the US
population in 2017, they accounted for 24.8% of hospi-
talizations [3]. Likewise, while the overall 30-day re-
admission rate of hospitalized patients in the US was
13.9%, the readmission rate for DM patients was 20.5%
in 2014 [4]. The social determinants of health among
DM patients have been associated with health outcomes.
Social determinants, such as socioeconomic status (SES),
ethnicity, and other non-medical factors, such as phys-
ical and social environments, access to medical services,
and social and health policies, influence health and mor-
tality outcomes because benefits of medical advances
may be more likely to flow to those with resources that
enable them to avoid health risks or adopt protective
strategies [5–7]. For example, DM patients who have
lower SES are more likely to experience 30-day readmis-
sions than other populations of DM patients [4]. Im-
proving access to healthcare would mitigate negative
health outcomes [5]. Hence, having health insurance
provides DM patients with access to care to control their
disease progression. We explored the association be-
tween types of insurance and health outcomes for a sam-
ple of DM patients.
In 2018, 91.5% of the U.S. population have health in-
surance. Private health insurance covered two-thirds,
whereas public insurance, administered by the Centers
for Medicare and Medicaid Services, covered the
remaining one-third of the insured [8]. Within public in-
surance, Medicare, a federal program, provides health
coverage for the disabled and individuals 65 years or
older, or the elderly. Medicaid, in contrast, is a state and
federal program that provides health coverage for low-
income individuals.
Younger enrollees on government and private insur-
ance plans have different health outcomes. For example,
in a recent study, Medicare beneficiaries under 65 years
old were more likely to be obese compared to those who
have commercial insurance [9]. In another study of DM
adults, those on Medicare plans were less likely to be
treated with new medications to lower their glucose
levels compared to those on private insurance plans
[10]. Nevertheless, Davis et al. [11] found that Medicare
beneficiaries under the age of 65 years were generally
more satisfied with their healthcare coverage vis-à-vis
those who were covered by private insurance. Medicare
beneficiaries reported fewer problems obtaining access
to care, greater confidence in their access, and fewer in-
stances of financial hardship due to medical bills [12].
Medicare eligibility for the elderly is associated with in-
creased health insurance coverage, improved health ac-
cess, and reduced out-of-pocket healthcare expenses for
those with chronic illnesses [13]. However, in comparing
the health outcomes between patients on Medicare in-
surance with those on private insurance, Medicare pa-
tients were on average unequivocally older than their
private insurance counterparts, confounding the results
[14]. Little is known about health outcome differences
between elderly Medicare beneficiaries with a chronic
illness and their counterparts with private insurance.
This study seeks to explore if there are differences.
We choose a state with capitation funding to rule out
limitations to healthcare access due to financial con-
siderations. We contribute to the literature by clarify-
ing results on the association between types of
insurance plans and health outcomes of elderly DM
patients where the payment rate to healthcare pro-
viders is the same, thus controlling for financial con-
siderations. We hope that by controlling for financial
considerations, our study will provide a clearer under-
standing of how different types of insurance plans are
associated with health outcomes for a sample of eld-
erly patients with a chronic illness who need constant
access to healthcare.
In both government and private insurance programs,
enrollees can choose between fee-for-service (FFS) and
managed care (MC) plans. In FFS plans, enrollees face
no restrictions in their choice of healthcare providers,
whereas those who choose MC plans are restricted to
healthcare providers in specific networks [15]. In FFS
plans, healthcare providers are paid directly by the in-
surer for each individual service rendered to a patient.
Concerns have been raised that this system has resulted
in excessive prescriptions and test orderings [16]. Over-
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diagnosis has been associated with poorer health out-
comes for patients from overtreatment, unnecessary
therapies, or psychological suffering during invasive
tests [17]. Additionally, since FFS patients can choose
multiple healthcare providers for the same illness, frag-
mentation of care occurs. When different healthcare
providers prescribe different care plans, negative health
outcomes may result [18]. In the MC plan, a specific
amount is established for each insured person when the
enrollee receives care from approved providers regard-
less of the number of procedures undertaken [15, 18,
19]. To minimize the number of procedures, the
healthcare provider actively manages the enrollee’s
health. MC enrollees with chronic diseases are re-
quired to participate in regular preventive visits,
which improves health outcomes and the single-point
access prevents fragmentation of care and provides
continuity of care [19].
Health maintenance organizations, which provide
MC plans, generally report lower overall rates of
hospitalization, shorter length of stay (LOS), and
fewer hospital readmissions [19]. Some argue that the
better health outcomes among enrollees on MC plans
vis-à-vis FFS plans are the result of selection bias in
which MC programs enroll healthier patients. How-
ever, recent studies that used the 2010–2016 Medi-
care Current Beneficiary Survey found no significant
differences between the self-reported health statuses
and the presence of chronic conditions of Medicare
FFS and Medicare MC beneficiaries [20, 21]. Specific-
ally, Park et al. [21] found no significant differences
in the health status of Medicare FFS and Medicare
MC beneficiaries who have diabetes. Yayac et al. [22]
also found no significant differences between Medi-
care FFS and Medicare MC participants in terms of
LOS or hospital readmissions after total hip and knee
arthroplasty. Hence, recent studies suggest that Medi-
care MC beneficiaries are not healthier than those in
Medicare FFS plans. In fact, Panagiotou et al. [23] re-
ported that during the period of 2011–2014, Medicare
MC beneficiaries had higher risk-adjusted 30-day
readmission rates than Medicare FFS for acute myo-
cardial infarction, congestive heart failure, and pneu-
monia after correcting for under-reported hospital
admissions in the Healthcare Effectiveness and Infor-
mation Set. Likewise, Figueroa et al. [24] reported
that Medicare MC beneficiaries had more comorbidi-
ties than Medicare FFS beneficiaries and the former
were more likely to receive secondary prevention
treatments. Park et al. [21, 25] found that Medicare
beneficiaries with new diagnoses of diabetes tend to
switch from Medicare FFS into Medicare MC plans
so that sicker patients have access to a more efficient
care delivery system.
Methods
Study design, data, and sample
This was a retrospective, cross-sectional archival record
study. Data was obtained from the 2012 Maryland Clin-
ical Public Use Data.1 Because this is a public data
source containing no personal identifiers, the Institu-
tional Review Board (IRB) of our university determined
that this study was exempt from IRB review for research
purposes (IRB Reference #164798–1).
Results from past studies that include variables on so-
cial determinants of health have been confounded by fi-
nancial considerations in which access and level of care
provided to enrollees were related to costs. We choose
Maryland as our study site because this state applies the
same capitation model for all enrollees in government
insurance plans. A federal waiver exempts hospitals in
Maryland from the national Medicare fee schedule. As a
result, Maryland hospitals are placed under the same
payer system to contain cost growth, improve access to
care, and implement payment innovations. Both Medi-
care FFS and MC healthcare providers are paid the same
for each enrollee and have the same incentive to attract
healthy participants to minimize costs. Consequently,
confounds in utilization rates and differences in the re-
striction of care between Medicare FFS and Medicare
MC patients are minimized because the payment rate to
healthcare providers in Maryland is the same for both
groups of patients [26].
The data included 694,488 patients who were hospital-
ized in Maryland hospitals in 2012. Among these pa-
tients, 85,712 (12.3%) were diagnosed with DM. We
limit the DM sample to those who were at least 65 years
old who had the opportunity to choose between Medi-
care and private insurance. We excluded Medicaid
enrollees because it is not a federal-only insurance pro-
gram but involves state partnership. The final sample for
analysis included 43,519 elderly DM patients comprising
37,825 Medicare FFS, 2736 Medicare MC, 1926 Private
FFS, and 1032 Private MC patients.
Outcome variables
Three health outcomes were examined in this study.
The first was hospital length of stay (LOS) measured in
days, which indicates the efficiency and quality of hos-
pital care [27]. Related to quality of care is the 30-day re-
admission from the indexed DM-related discharge,
which was coded as 1 for yes and 0 for no. The third
outcome was whether the patient was hospitalized as
having end-stage renal disease (ESRD), which was coded
as 1 for yes and 0 for no. ESRD is a costly and disabling
condition associated with DM [28].
1https://hscrc.maryland.gov/Pages/hsp-data-request.aspx
Lee et al. BMC Health Services Research          (2021) 21:495 Page 3 of 10
Control and predictor variables
Three groups of control variables were included in the
analyses as they have associations with health outcomes
even though they were not the focus of this study. The
first group of control variables were related to hospital
characteristics where the patient received care. Specific-
ally, hospital size and teaching status have been associ-
ated with access to specialists and resources, which
influence health outcomes [15]. Hospital size was coded
as 1 if the hospital had more than 400 beds and as 0
otherwise. Operating costs increase for hospitals with
over 400 beds due to diseconomies of scale [29]. The
teaching status of the hospital was coded as 1 if the hos-
pital is an academic teaching hospital and as 0 otherwise.
30-day mortality rate was found to be lower in teaching
hospitals compared to non-teaching hospitals [30].
The second group of control variables that were re-
lated to health outcomes but were not the focus of this
study were the patients’ demographics, behavioral, and
biological factors. Age, measured in years, was included
because almost 80% of US adults 65 years and older have
some form of dysglycemia, which has significant implica-
tions for DM [31]. Gender, coded as 1 for male and 0
for female, was included because DM is more common
among men [32]. Marital status, measured as 1 for mar-
ried and 0 otherwise, was included because unmarried
individuals tend to have higher health risks than their
married counterparts [33]. Smoking, measured as 1 for
smoking and 0 otherwise, has been associated with in-
creased risk of Type 2 DM [34]. Asthma, measured as 1
for asthma and 0 otherwise, and tuberculosis (TB), mea-
sured as 1 for tuberculosis and 0 otherwise, were in-
cluded because DM was associated with impaired
pulmonary function [35]. Depression, measured as 1 for
depression and 0 otherwise, was included because mood
has been associated with adherence to medication regi-
mens for glycemic control [36]. Finally, obesity, mea-
sured as 1 for obesity and 0 otherwise, is associated with
DM because obese individuals secrete resistin, a hor-
mone that causes insulin resistance [37].
The third group of control variables were the patients’
social determinants of health. The first variable was SES.
Since the 2012 Maryland Clinical Public Use Data did
not provide the patients’ income data, we used the pa-
tients’ zip codes to approximate average household in-
come in accordance with common practices in the
literature [15]. A second variable was the size of the pa-
tients’ residential neighborhood. Patients who live in
metropolitan areas, with populations greater than 1 mil-
lion people, were coded as living in Urban Neighbor-
hoods and were coded as 1 to reflect the degree of
congestion and access to community resources and 0
otherwise [15]. Rural areas have fewer physicians per
capita than urban areas, which indicate inequitable
healthcare access [38]. A third variable was race, mea-
sured as two dichotomous variables, White and Black,
because race and ethnicity significantly affect health out-
comes due to food insecurity, which can affect glycemic
control [39]. By controlling for social determinants of
health disparities that has traditionally been the result of
a lack of insurance access, we limit selection bias associ-
ated with financial considerations that include only
healthier patients who have access to insurance and
healthcare.
Our predictor variables were the four different types of
insurance plans: Medicare FFS, Medicare MC, Private
FFS, and Private MC insurance plans.
Statistical analysis
We used Student’s t-test to make three pairs of compari-
sons to determine the extent to which the profiles of
elderly DM patients were different for those enrolled in
each type of insurance plan. The first pair of comparison
was made between Medicare and private insurance
enrollees, the second pair was made between Medicare
FFS and Medicare MC enrollees, and the final pair was
made between Private FFS and Private MC enrollees. To
partial out the effects of the control variables, we used
multiple hierarchical regression analysis to isolate the in-
dependent association between insurance plans with
LOS and used logistic hierarchical regression analyses to
isolate the independent association between insurance
plans with 30-day readmission and ESRD. Hierarchical
regression analysis determines whether insurance plans
explained additional variance on the outcome variables,
after hospital characteristics, patient demographics, be-
havioral, and biological factors, and social determinants
of health were considered. We entered the data in incre-
mental blocks of information first by hospital character-
istics, second by patient demographics, behavioral, and
biological factors, third by social determinants of health,
and fourth by insurance to separate the various associa-
tions with the outcome variables. We report the stan-
dardized regression coefficients or beta, which considers
the standard errors of the regression coefficients, for
multiple regression analysis and Odds Ratio for logistic
regression analyses, which indicates the likelihood that
an outcome is associated with the predictor variable. An
Odds Ratio below 1.0 indicates a likelihood of less than
100% that the predictor is associated with the outcome,
whereas an Odds Ratio above 1.0 indicates a likelihood
greater than 100% that the predictor is associated with
the outcome.
Results
Table 1 shows the descriptive statistics of the variables.
The mean LOS in our sample was 4.45 days, with a
standard deviation of 4.18 days, the mean percentage of
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patients who were readmitted within 30-days after dis-
charge was 15.71, and 5.09% of patients were hospital-
ized with ESRD.
Table 2 shows differences between the demographic
and medical status profiles of elderly DM patients en-
rolled in Medicare and private insurance plans, Medicare
FFS and Medicare MC plans, and Private FFS and Pri-
vate MC plans. Table 2 indicates that among this sample
of elderly DM patients, there were no statistical differ-
ences between Medicare and private insurance enrollees
in their health status in terms of smoking (p = 0.17),
asthma (p = 0.29), TB (p = 0.24), and obesity (p = 0.09).
Although the income was significantly higher for this
sample of elderly DM patients with private insurance
(mean income = $74,624) compared to those with Medi-
care insurance (mean income = $69,774), the difference
was less $5000. Likewise, Table 2 shows that the health
status differences between Medicare FFS and Medicare
MC enrollees were not significantly different for smok-
ing (p = 0.40), asthma (p = 0.15), TB (p = 0.33), depres-
sion (p = 0.67), and obesity (p = 0.09). The income of
enrollees in Medicare MC (mean income = $58,067) was
significantly lower than the income of enrollees in Medi-
care FFS (mean income = $70,624). Medicare MC
enrollees were also more likely to live in urban neigh-
borhoods (79.3%) compared to Medicare FFS enrollees
(59.3%). Similarly, Table 2 shows that this sample of eld-
erly DM patients enrolled in Private FFS and Private MC
enrollees were not significantly different in terms of
Table 1 Descriptive Statistics
Mean Std. Deviation
Hospitals with over 400 beds (%) 32.97
Teaching hospital (%) 35.47
Age (years) 76.87 7.813
Male (%) 44.18
White (%) 63.30
African American (%) 32.25
Married (%) 44.85
Income ($) $70,103.46 $25,408.93






Environmental Hazards (%) 0.33
Medicare Fee-for-Service (%) 86.92
Medicare Managed Care (%) 6.29
Private Fee-for-Service (%) 4.43
Private Managed Care (%) 2.37
Length of Stay (LOS) days 4.45 4.183
End Stage Renal Disease (ESRD) (%) 5.09
30-day Readmission (%) 15.71
n = 43,519
Table 2 Comparison of Enrollee Profiles between Insurance Types
Medicare Private P-value Medicare FFS Medicare MC P-value Private FFS Private MC P-value
Hospitals> 400 beds (%) 32.8 35.1 0.01 31.8 47.3 <.001 35.8 33.9 0.33
Teach hospital (%) 35.3 37.3 0.03 33.9 55.2 <.001 37.8 36.4 0.47
Age (years) 77.22 72.07 <.001 77.25 76.72 <.001 71.95 72.28 0.22
Male (%) 43.23 57.2 <.001 43.5 39.2 <.001 59.1 53.6 <.01
Married (%) 43.53 63.02 <.001 44.3 32.8 <.001 64.8 59.6 <.01
Smoking (%) 14.62 15.55 0.17 14.58 15.17 0.40 16.10 14.53 0.29
Asthma (%) 16.05 15.28 0.29 15.98 17.03 0.15 15.06 15.70 0.67
TB (%) 8.31 8.92 0.24 8.27 8.81 0.33 9.40 8.04 0.22
Depression (%) 10.31 8.99 0.02 10.33 10.05 0.67 9.35 8.33 0.38
Obesity (%) 25.28 26.71 0.09 25.25 25.66 0.63 26.22 27.62 0.43
White (%) 63.32 62.95 0.68 64.8 42.4 <.001 64.3 60.4 0.03
Black (%) 32.41 29.99 <.01 30.8 54.5 <.001 29.1 31.6 0.17
Income ($) 69,774 74,624 <.001 70,624 58,067 <.001 72,776 78,049 <.001
Urban (%) 60.69 56.6 <.001 59.3 79.3 <.001 57.8 54.2 0.06
Environmental Hazard (%) 0.34 0.30 0.78 0.31 0.41 0.34 0.28 0.35 0.38
LOS (days) 4.47 4.12 <.001 4.47 4.51 0.67 4.15 4.05 0.51
ESRD (%) 5.2 3.5 <.001 5.2 5.4 0.63 3.5 3.5 0.99
30-day Readmit (%) 15.9 13.4 <.001 16.0 14.3 0.02 14.3 11.6 0.04
n 40,561 2958 37,825 2736 1926 1032
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smoking (p = 0.29), asthma (p = 0.67), TB (p = 0.22), de-
pression (p = 0.38), and obesity (p = 0.43). In sum, the t-
tests results in Table 2 show minimal statistical differ-
ences in the health status of elderly DM patients who
were enrolled either between Medicare and private in-
surance plans or between FFS and MC insurance plans.
We factored out any variations in medical status differ-
ences between enrollees in Medicare and private insur-
ance, Medicare FFS and Medicare MC insurance, as well
as Private FFS and Private MC insurance by controlling
for them using hierarchical regression analyses. By consid-
ering the health statuses of elderly DM patients before the
insurance variable, we isolated the additional variance ex-
plained by insurance on health outcomes. Table 3 shows
the hierarchical linear regression results of insurance on
LOS after factoring out the control variable pertaining to
hospital characteristics, patient demographics, behavioral,
and biological factors, and social determinants of health.
Table 3 shows that after factoring out the control vari-
ables, elderly DM patients who enrolled in Medicare FFS
had significantly longer LOS at p < 0.01, while those who
enrolled in Medicare MC, Private FFS, and Private MC
had significantly lower LOS at p < 0.05.
Table 4 shows the hierarchical logistic regression re-
sults of insurance on 30-day readmission after factoring
out hospital characteristics, patient demographics,
behavioral, and biological factors, and social determi-
nants of health. Table 4 shows that elderly DM patients
who enrolled in Medicare FFS had a significantly higher
likelihood of being readmitted within 30 days (OR = 1.16,
p < 0.001) while those who enrolled in Medicare MC
(OR = 0.88, p = 0.03) and Private MC (OR = 0.75, p <
0.01) had a significantly lower likelihood of being re-
admitted within 30 days after discharge from the indexed
DM admission. Elderly DM patients who enrolled in Pri-
vate FFS did not reach a level of significance for 30-day
readmission at p < 0.05. Thus, the data indicates that this
sample of elderly DM patients who enrolled in Private
MC had the lowest likelihood among the four types of
insurance plans to be readmitted within 30 days while
those who enrolled in Medicare FFS had the highest
likelihood.
Table 5 shows the hierarchical logistic regression re-
sults of insurance on ESRD after factoring out hospital
characteristics, patient demographics, behavioral, and
biological factors, and social determinants of health.
Table 5 shows that this sample of elderly DM patients
who enrolled in Medicare FFS had a significantly higher
likelihood of ESRD (OR = 1.44, p < 0.001) while those en-
rolled in Medicare MC (OR = 0.83, p = 0.03), Private FFS
(OR = 0.28, p < 0.001), and Private MC (OR = 0.58, p <
0.01) had significantly lower likelihoods of having ESRD.
Table 3 The Relationship between Insurance Type and LOS








Beta p-value Beta p-value Beta p-value Beta p-value Beta p-value
Block 1: Hospital Type
Hospital with > 400 beds 0.04 < 0.001 0.04 < 0.001 0.02 < 0.001 0.04 < 0.001 0.04 < 0.001
Teaching hospital 0.02 0.02 0.02 0.02 −0.02 < 0.01 0.02 0.02 0.02 0.02
Block 2: Patient Demographics, Behavioral, and Biological Factors
Age (years) 0.03 < 0.001 0.03 < 0.001 − 0.04 < 0.001 0.03 < 0.001 0.03 < 0.001
Male −0.01 0.01 0.01 0.92 0.03 < 0.001 0.01 0.96 0.01 0.93
Married −0.04 < 0.001 − 0.04 < 0.001 − 0.02 < 0.001 − 0.04 < 0.001 − 0.04 < 0.001
Smoking 0.03 < 0.001 0.03 < 0.001 − 0.01 0.30 0.03 < 0.001 0.03 < 0.001
Asthma −0.01 0.12 −0.01 0.12 −0.03 < 0.001 − 0.01 0.12 − 0.01 0.12
Tuberculosis 0.09 < 0.001 0.09 < 0.001 −0.03 < 0.001 0.09 < 0.001 0.09 < 0.001
Depression −0.02 < 0.001 −0.02 < 0.001 − 0.01 < 0.01 −0.02 < 0.001 − 0.02 < 0.001
Obesity 0.01 0.13 0.01 0.14 0.11 < 0.001 0.01 0.14 0.01 0.13
Block 3: Social Determinants
White −0.02 0.16 −0.02 0.15 −0.06 < 0.001 −0.02 0.15 −0.02 0.15
African American −0.01 0.62 −0.01 0.59 0.07 < 0.001 −0.01 0.60 −0.01 0.60
Income −0.01 0.11 −0.01 0.15 −0.01 0.84 −0.01 0.12 −0.01 0.14
Urban Neighborhood −0.03 < 0.001 −0.03 < 0.001 0.01 0.03 −0.03 < 0.001 −0.03 < 0.001
Environmental Hazards 0.01 0.01 0.01 < 0.01 −0.01 0.27 0.01 < 0.01 0.01 < 0.01
Block 4: Insurance 0.01 < 0.01 −0.01 0.01 − 0.01 0.03 −0.01 0.02
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Thus, the data indicates that this sample of elderly DM
patients who enrolled in Private FFS had the lowest like-
lihood while those enrolled under Medicare FFS had the
highest likelihood among the four types of insurance to
be hospitalized for ESRD.
Discussion
Past studies reported associations between insurance
plans and health outcomes of younger enrollees [9, 10].
This study explored the association between insurance
and health outcomes among DM patients who were 65
years or older. The t-tests results for this sample of eld-
erly DM patients showed minimal statistical differences
in the health status between those who were enrolled in
FFS and MC insurance plans. This lack of statistical dif-
ferences between MC and FFS enrollees were similar to
the reports of Park et al. [21] and Yayac et al. [22]. The
mean income of Medicare MC enrollees in this sample
of elderly DM patients was significantly lower than those
enrolled in Medicare FFS. As well, Medicare MC enrol-
lees were more likely to live in urban neighborhoods
compared to Medicare FFS enrollees. The extant litera-
ture, which suggests that individuals with lower SES and
those who live in urban neighborhoods more likely ex-
perience adverse health outcomes, would indicate that
the Medicare MC enrollees of this sample of elderly DM
patients are not healthier compared to those in Medicare
FFS plans, which are in line with the reports of Panagio-
tou [23] and Figuero [24].
To rule out confounds on health outcomes that arise
from hospital characteristics, patient demographics, be-
havioral, and biological factors, and their social determi-
nants of health, we factored out these confounds in the
regression analyses. The data indicates that elderly DM
patients who enrolled in Medicare FFS had significantly
worse health outcomes in terms of LOS, 30-day read-
missions, and ESRD compared to those enrolled in the
other three types of insurance. Elderly DM patients who
enrolled in Private MC had the lowest likelihood of ex-
periencing a 30-day readmission, while those who en-
rolled in Private FFS had the lowest likelihood of having
ESRD. Private FFS enrollees had lower ESRD compared
to Medicare MC or Private MC plans. Thus, the benefits
of MC plans were not as strong as those indicated in
past studies [18, 19]. Only 30-day readmission risk was
lower in MC plans compared to FFS plans.
Given the cross-sectional nature of the data from a
single year, we were limited by the ability to determine
causality among the factors associated with health out-
comes for DM patients 65 years and older. Even though
Table 4 The Relationship between Insurance Type and 30-Day Readmission








Odds Ratio p-value Odds Ratio p-value Odds Ratio p-value Odds Ratio p-value Odds Ratio p-value
Constant 0.10 < 0.001 0.10 < 0.001 0.11 < 0.001 0.11 < 0.001 0.11 < 0.001
Block 1: Hospital Type
Hospital with > 400 beds 1.00 0.97 1.00 0.96 1.00 0.94 1.00 0.97 1.00 0.99
Teaching hospital 0.78 < 0.001 0.79 < 0.001 0.79 < 0.001 0.78 < 0.001 0.78 < 0.001
Block 2: Demographics & Medical
Age (years) 1.00 0.47 1.00 0.75 1.00 0.47 1.00 0.57 1.00 0.647
Male 1.01 0.77 1.01 0.70 1.01 0.77 1.01 0.74 1.01 0.74
Married 0.92 < 0.01 0.93 < 0.01 0.92 < 0.01 0.93 < 0.01 0.93 < 0.01
Smoking 1.11 < 0.01 1.10 < 0.01 1.11 < 0.01 1.10 < 0.01 1.10 < 0.01
Asthma 1.01 0.69 1.02 0.69 1.02 0.69 1.01 0.70 1.01 0.69
Tuberculosis 1.49 < 0.001 1.49 < 0.001 1.49 < 0.001 1.49 < 0.001 1.49 < 0.001
Depression 1.13 < 0.01 1.13 < 0.01 1.13 < 0.01 1.13 < 0.01 1.13 < 0.01
Obesity 1.02 0.55 1.02 0.58 1.02 0.56 1.02 0.56 1.02 0.56
Block 3: Social Determinants
White 1.77 < 0.001 1.76 < 0.001 1.76 < 0.001 1.76 < 0.001 1.76 < 0.001
African American 1.56 < 0.001 1.57 < 0.001 1.57 < 0.001 1.56 < 0.001 1.56 < 0.001
Income 1.00 < 0.01 1.00 < 0.001 1.00 < 0.001 1.00 < 0.01 1.00 < 0.01
Urban Neighborhood 1.28 < 0.001 1.28 < 0.001 1.28 < 0.001 1.28 < 0.001 1.28 < 0.001
Environmental Hazards 0.88 0.59 0.88 0.59 0.88 0.59 0.88 0.59 0.88 0.58
Block 4: Insurance 1.16 < 0.001 0.88 0.03 0.93 0.25 0.75 < 0.01
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the estimated mean income difference between elderly
DM patients on Medicare plans and private insurance
plans was less than $5000, the data did not provide in-
formation on the employment status of these elderly
DM patients. Since the data is publicly de-identified hos-
pital discharge data, collecting follow-up data on pa-
tients’ characteristics, such as their employment and
other SES data, was challenging. Employment status may
be an important factor that influences health outcomes.
A recent study indicated that younger diabetic adults
under 66 years old were more likely to receive new med-
ications to lower their glucose levels in private insurance
plans than Medicare plans [9]. Thus, a future research
that explores the health outcomes of elderly DM patients
who continue in employment to receive better treatment
from employer-sponsored commercial insurance plans
would add to the extant literature. Public discharge data
also did not record the segmentation of private health
plans by socioeconomic categories, which makes it diffi-
cult to determine whether high deductible plans were se-
lected by individuals who fall into higher socioeconomic
categories because they provide access to Health Saving
Accounts with tax advantages.
Nevertheless, given the data restrictions, the results in-
dicate that the selection of insurance choices was
associated with health outcomes for a sample of older
patients with DM. Future research could mitigate some
of these unanswered questions by utilizing longitudinal
data. Additionally, a future study could validate the re-
sults by examining data for a different chronic illness for
which insurance plans and patient characteristics could
also play important roles on health outcomes.
Conclusion
The data suggests that Medicare fee-for-service plans
where enrollees in the government insurance plan face
no restrictions in their choice of healthcare providers
had worse health outcomes in terms of length of hospital
stay, 30-day readmission, and end-stage renal disease
rates compared to those enrolled in Medicare Managed
Care plans or private insurance plans. Public policy
could be made to provide incentives for older population
with DM to transfer their enrollment to Medicare man-
aged care or private insurance plans. There could even
be greater public-private health partnerships with insur-
ance companies and healthcare providers to mitigate the
health risks of those with chronic illnesses.
Abbreviations
DM: Diabetes mellitus; FFS: Fee-for-service; MC: Managed care; LOS: Length
of stay; ESRD: End-stage renal disease
Table 5 The Relationship between Insurance Type and ESRD








Odds Ratio p-value Odds Ratio p-value Odds Ratio p-value Odds Ratio p-value Odds Ratio p-value
Constant 0.25 < 0.001 0.21 < 0.001 0.26 < 0.001 0.28 < 0.001 0.27 < 0.001
Block 1: Hospital Type
Hospital with > 400 beds 1.27 < 0.001 1.27 < 0.001 1.27 < 0.001 1.27 < 0.001 1.28 < 0.001
Teaching hospital 0.82 < 0.01 0.83 < 0.01 0.83 < 0.01 0.82 < 0.01 0.82 < 0.01
Block 2: Demographics & Medical
Age (years) 0.98 < 0.001 0.98 < 0.001 0.98 < 0.001 0.98 < 0.001 0.98 < 0.001
Male 1.33 < 0.001 1.34 < 0.001 1.33 < 0.001 1.34 < 0.001 1.33 < 0.001
Married 0.85 0.001 0.85 0.001 0.85 0.001 0.86 < 0.01 0.85 0.001
Smoking 0.94 0.35 0.94 0.36 0.94 0.36 0.94 0.34 0.94 0.34
Asthma 0.68 < 0.001 0.69 < 0.001 0.68 < 0.001 0.68 < 0.001 0.68 < 0.001
Tuberculosis 0.48 < 0.001 0.48 < 0.001 0.48 < 0.001 0.48 < 0.001 0.48 < 0.001
Depression 0.78 < 0.01 0.77 < 0.01 0.78 < 0.01 0.77 < 0.01 0.77 < 0.01
Obesity 2.58 < 0.001 2.58 < 0.001 2.58 < 0.001 2.58 < 0.001 2.58 < 0.001
Block 3: Social Determinants
White 0.52 < 0.001 0.51 < 0.001 0.52 < 0.001 0.52 < 0.001 0.52 < 0.001
African American 1.53 < 0.001 1.53 < 0.001 1.54 < 0.001 1.52 < 0.001 1.52 < 0.001
Income 1.00 0.74 1.00 0.63 1.00 0.62 1.00 0.79 1.00 0.84
Urban Neighborhood 1.12 0.04 1.12 0.04 1.12 0.04 1.12 0.04 1.12 0.05
Environmental Hazards 0.57 0.28 0.56 0.27 0.57 0.28 0.57 0.27 0.57 0.27
Block 4: Insurance 1.44 < 0.001 0.83 0.03 0.28 < 0.001 0.58 < 0.01
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